15 completed. 15 Phase 3, 7 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 15 | Completed 15 |
| Phase 2 | 7 | Completed 7 |
Follow Personality Disorders: new trials by email Literature Review of Personality Disorders trials Research Report on Personality Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating the Safety and Tolerability of Brexpiprazole in the Treatment of Adults With Borderline Personality Disorder (BPD) Brexpiprazole - Borderline Personality Disorder | Phase 2 / Phase 3 | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | 201 | 2020-01-13 | 2024-10-03 |
| The Short-Term MBT Project Short-term MBT, Long-term MBT - Borderline Personality Disorder | Phase 3 | Completed | Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital | 166 | 2018-09-24 | 2024-01-12 |
| The Staged Treatment in Early Psychosis Study Support and Problem Solving Therapy, Cognitive Behavioural Case Management, Fluoxetine - Psychotic Disorders, Personality Disorders | Phase 3 | Completed | Orygen | 342 | 2016-04-01 | 2025-10-02 |
| Omega-3 Supplementation and Behavior Problems Omega-3 supplemented drink, Smartfish - Aggression, Antisocial Behavior | Phase 2 / Phase 3 | Completed | Dr. Annis Fung | 324 | 2015-02-01 | 2018-07-18 |
| Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function Vitamin C +prenatal vitamin, Placebo tablet+prenatal vitamin - Pulmonary Function; Newborn, Abnormal, Infant Wheeze | Phase 2 / Phase 3 | Completed | Oregon Health and Science University | 252 | 2012-12-01 | 2019-04-17 |
| Clinical Research Study to Evaluate Selegiline in the Treatment of Borderline Personality Disorder Selegiline, Placebo (for Selegiline) - Borderline Personality Disorder | Phase 3 | Completed | Mood and Anxiety Research, Inc | 30 | 2012-10-01 | 2015-10-08 |
| Omega-3 Supplements to Reduce Antisocial Behaviour in Young Offenders Omega-3, Placebo, Treatment as Usual - Antisocial Behavior | Phase 2 / Phase 3 | Completed | Singapore Prison Service | 181 | 2011-03-01 | 2018-08-13 |
| Effect of Omega-3 Supplementation on Child Behavior Problems omega-3 - Antisocial, Aggressive | Phase 2 / Phase 3 | Completed | Joint Child Health Project, Mauritius | 200 | 2010-03-01 | 2013-12-19 |
| Seroquel Extended Release (XR) for the Management of Borderline Personality Disorder (BPD) quetiapine extended-release, Placebo - Borderline Personality Disorder | Phase 3 | Completed | University of Minnesota | 95 | 2008-06-01 | 2017-03-09 |
| Quetiapine Treatment for Symptoms Associated With Borderline Personality Disorder Quetiapine Fumarate - Borderline Personality Disorder | Phase 3 | Completed | University of Medicine and Dentistry of New Jersey | 15 | 2005-05-01 | 2008-06-10 |
| Olanzapine in Patients With Borderline Personality Disorder Olanzapine, placebo - Borderline Personality Disorder | Phase 3 | Completed | Eli Lilly and Company | 300 | 2004-03-01 | 2006-07-24 |
| Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder Olanzapine - Borderline Personality Disorder | Phase 3 | Completed | Eli Lilly and Company | 450 | 2004-02-01 | 2006-07-24 |
| Personality-targeted Interventions for Adolescent Alcohol Misuse PRE-Venture: Personality Risk Education - Alcohol Abuse, Drug Abuse | Phase 2 / Phase 3 | Completed | King's College London | 710 | 2003-11-01 | 2011-06-27 |
| BOSCOT : A Randomised Controlled Trial of Cognitive Behavioural Therapy in Borderline Personality Disorder Cognitive Behavioural Therapy, Treatment as usual - Borderline Personality Disorder | Phase 3 | Completed | University of Aberdeen | 106 | 2002-02-01 | 2007-10-02 |
| First Experimental Study of Transference-Interpretations (FEST) Brief dynamic psychotherapy - Mood Disorders, Anxiety Disorders | Phase 2 / Phase 3 | Completed | University of Oslo | 100 | 1993-01-01 | 2007-08-27 |
Borderline Personality Disorder (8) · Antisocial Personality Disorder (5) · Anxiety Disorders (3) · Aggression (2) · Depression (2) · Alcoholism (1) · Behavior, Addictive (1) · Binge Drinking (1) · Conduct Disorder (1) · Fibromyalgia (1) · Headache (1) · Irritable Bowel Syndrome (1) · Mental Disorders (1) · Migraine Disorders (1)
Mental Disorders (14) · Behavior (4) · Behavioral Symptoms (4) · Aberrant Motor Behavior in Dementia (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Social Behavior (2) · Alcohol Drinking (1) · Alcohol-Related Disorders (1) · Attention Deficit and Disruptive Behavior Disorders (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Chemically-Induced Disorders (1) · Colonic Diseases (1)
Docosahexaenoic Acids (2) · Olanzapine (2) · Therapeutics (2) · Ascorbic Acid (1) · Cognitive Behavioral Therapy (1) · Fluoxetine (1) · Palliative Care (1) · Quetiapine Fumarate (1) · Selegiline (1) · brexpiprazole (1)
Eli Lilly and Company (2) · Dr. Annis Fung (1) · Joint Child Health Project, Mauritius (1) · King's College London (1) · Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital (1) · Mood and Anxiety Research, Inc (1) · Oregon Health and Science University (1) · Orygen (1) · Otsuka Pharmaceutical Development & Commercialization, Inc. (1) · Singapore Prison Service (1) · University of Aberdeen (1) · University of Medicine and Dentistry of New Jersey (1) · University of Minnesota (1) · University of Oslo (1)
United States (7) · United Kingdom (3) · Norway (2) · Argentina (1) · Australia (1) · Belgium (1) · China (1) · Denmark (1) · France (1) · Germany (1) · Mauritius (1) · Poland (1) · Portugal (1) · Romania (1) · Spain (1)
Adrian Raine (1) · Annis Fung, Ph.D. (1) · Cynthia T McEvoy, MD,MCR (1) · Cyril Dalais, MSc (1) · David J Rissmiller, DO (1) · Kate Davidson, PhD (1) · Patricia J. Conrod, Ph.D. (1) · Patrick McGorry, MD, PhD (1) · Paul J Markovitz, MD, PhD (1) · S. Charles Schulz, MD (1) · Sebastian Simonsen, PhD (1) · Tashneem Moohamed, BSc (1)
PMID 36375174, PMID 21095016, PMID 22967772, PMID 32368793, PMID 17012684, PMID 19043153, PMID 19254438, PMID 19845088, PMID 20048226, PMID 20732631, PMID 20869813, PMID 21535995, PMID 21859184, PMID 22373759, PMID 24677205, PMID 25146492, PMID 25404145, PMID 27600314, PMID 30522343, PMID 30865304, PMID 30953536, PMID 31651367, PMID 32252696, PMID 32404003, PMID 32880104, PMID 34321051, PMID 34538263, PMID 37378974, PMID 37935133, PMID 38413986, PMID 39558901, PMID 41044653, PMID 42363615
2019 (1), R01HL105447 (1), U01MH105258 (1)